Mingxu X. Da - Publications

Burden, Epidemiologic Patterns, and Risk Factors of Early-Onset GI Cancers in China, With Projections Till 2035: A National Ecologic Study.

Journal: JCO global oncology

Published: June 17, 2026

Retraction Note: Integration of bioinformatics and cellular experiments unveils the role of SYT12 in gastric cancer.

Journal: BMC cancer

Published: February 21, 2026

Interleukin-1α (IL-1α) in pancreatic ductal adenocarcinoma: implications for immunotherapy and molecular biomarkers.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 10, 2026

Crosstalk between NRP1 and autophagy in the tumor microenvironment: from molecular mechanisms to therapeutic targeting.

Journal: Frontiers in immunology

Published: January 13, 2026

Case Report: A giant dedifferentiated liposarcoma in the retroperitoneum.

Journal: Frontiers in oncology

Published: November 21, 2025

The Carcinogenic Role of HMGB1 and NF-κB in Gastric Adenocarcinoma.

Journal: Digestive diseases and sciences

Published: October 14, 2025

Pathologic complete response of advanced hepatoid adenocarcinoma of the stomach following immuno-chemotherapy and conversion surgery: a rare case report and review of the literature.

Journal: Frontiers in oncology

Published: June 17, 2025

KMT2A Histone Methyltransferase Contributes to Intrahepatic Cholangiocarcinoma Cell Growth by Promoting JAK2 Transcriptional Activation.

Journal: Combinatorial chemistry & high throughput screening

Published: June 17, 2025

RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway.

Journal: Discover oncology

Published: May 27, 2025

MT1JP/miR-103a-3p induce pyroptosis and regulate the tumor immune microenvironment in gastric cancer.

Journal: Scientific reports

Published: February 11, 2025

Raddeanoside R13 Inhibits Proliferation, Invasion, and Metastasis of Gastric Cancer Cells Based on Network Pharmacology and Experimental Validationnd Experimental Validation.

Journal: Current cancer drug targets

Published: January 20, 2025

Targeting miR-103a-3p/IGFBP5 axis: a potential therapeutic strategy for gastric cancer progression.

Journal: Discover oncology

Published: December 18, 2024